Silence Therapeutics (SLN) Interest & Investment Income (2020 - 2024)
Silence Therapeutics recorded quarterly Interest & Investment Income of $1.3 million in Q3 2024, down 5.18% quarter-over-quarter from $1.3 million in Q2 2024, and down 50.82% year-over-year from $2.6 million in Q4 2023.
Silence Therapeutics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $1.3 million for Q3 2024.
- In Q3 2024, Interest & Investment Income fell 50.82% year-over-year to $1.3 million; the TTM figure through Sep 2024 stood at $4.7 million (up 316.69% YoY), while the FY2023 annual figure was $1.8 million, up 14.0% from the prior year.
- Interest & Investment Income came in at $1.3 million for Q3 2024 at Silence Therapeutics, down from $1.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $189.7 million in Q3 2020 to a low of -$4.8 million in Q4 2022.
- A 5-year average of $11.7 million and a median of $425463.5 in 2023 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 17129.35% in 2022 and fell as far as 177430.05% in 2022.
- Silence Therapeutics' Interest & Investment Income stood at $290499.2 in 2020, then tumbled by 99.07% to $2696.0 in 2021, then slumped by 177430.05% to -$4.8 million in 2022, then soared by 165.01% to $3.1 million in 2023, then tumbled by 58.99% to $1.3 million in 2024.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $1.3 million, $1.3 million, and -$1.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | -1.02 Mn |
| Dec 31, 2023 | 3.11 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 425,463.47 |
| Mar 31, 2023 | -408,411.20 |
| Dec 31, 2022 | -4.78 Mn |
| Sep 30, 2022 | 5.10 Mn |
| Jun 30, 2022 | 842,481.20 |
| Mar 31, 2022 | 469,642.50 |
| Dec 31, 2021 | 2,696.02 |
| Sep 30, 2021 | 408,060.67 |
| Jun 30, 2021 | 306,102.49 |
| Mar 31, 2021 | -2,757.84 |
| Dec 31, 2020 | 290,499.22 |
| Sep 30, 2020 | 189.70 Mn |